Alisporivir plus ribavirin, interferon free or in combination with pegylated interferon, for hepatitis C virus genotype 2 or 3 infectionJean–Michel Pawlotsky, Robert Flisiak, Shiv Kumar Sarin et al.|Hepatology|2015Cited by 51
The Combination of Alisporivir plus an NS5A Inhibitor Provides Additive to Synergistic Anti-Hepatitis C Virus Activity without Detectable Cross-ResistanceUdayan Chatterji, Philippe Gallay, Katarzyna Gawlik et al.|Antimicrobial Agents and Chemotherapy|2014Cited by 37